SAN FRANCISCO, Calif., July 5, 2016 (GLOBE NEWSWIRE) — via PRWEB – PONTiS Orthopaedics, LLC (http://www.pontisorthopaedics.com), announced today that Company 1st-half 2016 total revenues were over 150% ahead of sales for the same period in 2015. The Company attributes its rapid sales growth to increasing acceptance of the PONTiS Flexor Tendon Repair System, the Company’s primary current product line. “Growing clinical acceptance of our Flexor repair products has created a very positive environment for the launch of our Achilles tendon repair system this year,” said Tom Ross, COO of PONTiS. “The benefits of our technology to both patient and surgeon are equally large in the foot & ankle surgery arena,” he continued.
About PONTiS Orthopaedics, LLC
Located in San Francisco, and directed by seasoned medical device executives, PONTiS has developed the unique PONTiS™ Surgical Instrument and Implant System for the repair of tendons and for re-connection of tendons to bones in the hand, wrist, elbow, shoulder, knee, foot and ankle.
The PONTiS technology has been documented to produce a stronger repair than current alternatives and also enables minimally invasive repair methods not previously available – reportedly requiring shorter OR times and allowing more rapid recovery. The PONTiS system for the repair of flexor tendons in the hand addresses a large market with over 150,000 potential procedures annually, in the USA alone. The company’s IP also accesses additional orthopedic markets and PONTiS has obtained FDA clearance for Achilles tendon repair at the ankle, Biceps tendon re-attachment at the elbow and shoulder, Patella tendon repair at the knee and ligament repair in the wrist.
Further information: Please contact Tom Ross, PONTiS COO, at tross(at)pontisorthopaedics(dot)com or 1-415-567-8935.
This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2016/07/prweb13529552.htm
Pontis Orthopaedics Tom Ross +1 408-656-1585
